Halda Therapeutics
Kelli Jones is an accomplished professional in the biopharmaceutical industry with extensive experience in in vivo pharmacology and research. Currently serving as Associate Director and Head of In Vivo Pharmacology at Halda Therapeutics since September 2021, Kelli has previously held various roles including Senior Research Scientist and Head of In-Vivo Operations at the same company. Prior experience includes positions as Research Scientist at Cybrexa Therapeutics and Scientist at FORMA Therapeutics, Inc. and Novartis Institutes for BioMedical Research. Kelli spent over a decade at Bristol-Myers Squibb as a Research Scientist and began a career in research with roles at the University of Pittsburgh and Yale University. Kelli holds a Bachelor of Science in Biology from Quinnipiac University and a Master's degree in Neuroscience from the University of Hartford.
This person is not in any teams
This person is not in any offices
Halda Therapeutics
1 followers
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic disease drivers to target cancer. This powerful technology is designed to overcome the known bypass mechanisms of drug resistance, a common limitation of today’s precision cancer medicines. Using a novel ‘hold and kill’ mechanism, RIPTAC therapeutics target cancer cells selectively by bringing two proteins together in a tightly regulated manner, causing the loss of an essential function for cell survival and subsequent cancer cell death. We have built a pipeline of RIPTAC therapeutics for major cancer types, uniquely addressing the unmet needs of drug resistant cancer patients, and we will continue to invent new medicines using our proprietary platform technology. We are a bold company where collaboration, passion, and creativity thrive, all of which allows us to push the boundaries of drug discovery to identify better solutions. Halda is proud to be a New Haven, CT based biotech, located with headquarters and state-of-the-art labs in Science Park.